Helen Heslop, MD
Baylor College of Medicine
Dr. Heslop is Dan L Duncan Chair, Professor of Medicine and Pediatrics at Baylor College of Medicine, and the Director of the Center for Cell and Gene Therapy at Baylor College of Medicine, Houston Methodist Hospital and Texas Children’s Hospital. She is also the Interim Director of the Dan L. Duncan Cancer Comprehensive Center at Baylor College of Medicine. She is a physician scientist engaged in translational research focusing on adoptive immunotherapy with gene-modified effector cells, to improve hemopoietic stem cell transplantation and cancer therapy. An additional focus in reconstituting antiviral immunity post-transplant. She has extensive experience in developing and conducting transplant studies and cell and gene therapy studies and currently serves as sponsor for over 20 Investigational New Drug applications for cell therapy products with the FDA. She serves as Principal Investigator on several peer-reviewed research programs, including an LLS Specialized Center of Research (SCOR) award on Immunotherapy for Hematologic Malignancies.